Osteopontin exacerbates the progression of experimental autoimmune myasthenia gravis by affecting the differentiation of T cell subsets
• Osteopontin (OPN) is an immunoregulatory factors involved in the development of autoimmune disease. • The expression of OPN is increased during the development of experiment autoimmune myasthenia gravis (EAMG). • The rats in the EAMG group were randomized to receive NaCl or different dose of OPN....
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Zhao, Jiarui [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2020 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
Enthalten in: International immunopharmacology - Laupland, Kevin B. ELSEVIER, 2022, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:82 ; year:2020 ; pages:0 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.intimp.2020.106335 |
|---|
| Katalog-ID: |
ELV05007668X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV05007668X | ||
| 003 | DE-627 | ||
| 005 | 20230624161820.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200518s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.intimp.2020.106335 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001997.pica |
| 035 | |a (DE-627)ELV05007668X | ||
| 035 | |a (ELSEVIER)S1567-5769(19)32908-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.75 |2 bkl | ||
| 100 | 1 | |a Zhao, Jiarui |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Osteopontin exacerbates the progression of experimental autoimmune myasthenia gravis by affecting the differentiation of T cell subsets |
| 264 | 1 | |c 2020 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • Osteopontin (OPN) is an immunoregulatory factors involved in the development of autoimmune disease. • The expression of OPN is increased during the development of experiment autoimmune myasthenia gravis (EAMG). • The rats in the EAMG group were randomized to receive NaCl or different dose of OPN. • OPN could regulate the differentiation of Th cells, especially Th1 and Treg cells. | ||
| 650 | 7 | |a Experimental autoimmune myasthenia gravis |2 Elsevier | |
| 650 | 7 | |a Osteopontin |2 Elsevier | |
| 650 | 7 | |a T helper cells |2 Elsevier | |
| 650 | 7 | |a Autoimmune disease |2 Elsevier | |
| 650 | 7 | |a B cells |2 Elsevier | |
| 700 | 1 | |a Jing, Jia |4 oth | |
| 700 | 1 | |a Zhao, Wei |4 oth | |
| 700 | 1 | |a Li, Xinrong |4 oth | |
| 700 | 1 | |a Hou, Lixuan |4 oth | |
| 700 | 1 | |a Zheng, Chunfeng |4 oth | |
| 700 | 1 | |a Kong, Qingfei |4 oth | |
| 700 | 1 | |a Li, Wenjin |4 oth | |
| 700 | 1 | |a Yao, Xiuhua |4 oth | |
| 700 | 1 | |a Chang, Lulu |4 oth | |
| 700 | 1 | |a Li, Hulun |4 oth | |
| 700 | 1 | |a Mu, Lili |4 oth | |
| 700 | 1 | |a Wang, Guangyou |4 oth | |
| 700 | 1 | |a Wang, Jinghua |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Laupland, Kevin B. ELSEVIER |t International immunopharmacology |d 2022 |g Amsterdam [u.a.] |w (DE-627)ELV00785823X |
| 773 | 1 | 8 | |g volume:82 |g year:2020 |g pages:0 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.intimp.2020.106335 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 44.75 |j Infektionskrankheiten |j parasitäre Krankheiten |x Medizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 82 |j 2020 |h 0 | ||
| author_variant |
j z jz |
|---|---|
| matchkey_str |
zhaojiaruijingjiazhaoweilixinronghoulixu:2020----:sepnieaebtshporsinfxeietluomueyshnarvsyfetn |
| hierarchy_sort_str |
2020 |
| bklnumber |
44.75 |
| publishDate |
2020 |
| allfields |
10.1016/j.intimp.2020.106335 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001997.pica (DE-627)ELV05007668X (ELSEVIER)S1567-5769(19)32908-X DE-627 ger DE-627 rakwb eng 610 VZ 44.75 bkl Zhao, Jiarui verfasserin aut Osteopontin exacerbates the progression of experimental autoimmune myasthenia gravis by affecting the differentiation of T cell subsets 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Osteopontin (OPN) is an immunoregulatory factors involved in the development of autoimmune disease. • The expression of OPN is increased during the development of experiment autoimmune myasthenia gravis (EAMG). • The rats in the EAMG group were randomized to receive NaCl or different dose of OPN. • OPN could regulate the differentiation of Th cells, especially Th1 and Treg cells. Experimental autoimmune myasthenia gravis Elsevier Osteopontin Elsevier T helper cells Elsevier Autoimmune disease Elsevier B cells Elsevier Jing, Jia oth Zhao, Wei oth Li, Xinrong oth Hou, Lixuan oth Zheng, Chunfeng oth Kong, Qingfei oth Li, Wenjin oth Yao, Xiuhua oth Chang, Lulu oth Li, Hulun oth Mu, Lili oth Wang, Guangyou oth Wang, Jinghua oth Enthalten in Elsevier Science Laupland, Kevin B. ELSEVIER International immunopharmacology 2022 Amsterdam [u.a.] (DE-627)ELV00785823X volume:82 year:2020 pages:0 https://doi.org/10.1016/j.intimp.2020.106335 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.75 Infektionskrankheiten parasitäre Krankheiten Medizin VZ AR 82 2020 0 |
| spelling |
10.1016/j.intimp.2020.106335 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001997.pica (DE-627)ELV05007668X (ELSEVIER)S1567-5769(19)32908-X DE-627 ger DE-627 rakwb eng 610 VZ 44.75 bkl Zhao, Jiarui verfasserin aut Osteopontin exacerbates the progression of experimental autoimmune myasthenia gravis by affecting the differentiation of T cell subsets 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Osteopontin (OPN) is an immunoregulatory factors involved in the development of autoimmune disease. • The expression of OPN is increased during the development of experiment autoimmune myasthenia gravis (EAMG). • The rats in the EAMG group were randomized to receive NaCl or different dose of OPN. • OPN could regulate the differentiation of Th cells, especially Th1 and Treg cells. Experimental autoimmune myasthenia gravis Elsevier Osteopontin Elsevier T helper cells Elsevier Autoimmune disease Elsevier B cells Elsevier Jing, Jia oth Zhao, Wei oth Li, Xinrong oth Hou, Lixuan oth Zheng, Chunfeng oth Kong, Qingfei oth Li, Wenjin oth Yao, Xiuhua oth Chang, Lulu oth Li, Hulun oth Mu, Lili oth Wang, Guangyou oth Wang, Jinghua oth Enthalten in Elsevier Science Laupland, Kevin B. ELSEVIER International immunopharmacology 2022 Amsterdam [u.a.] (DE-627)ELV00785823X volume:82 year:2020 pages:0 https://doi.org/10.1016/j.intimp.2020.106335 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.75 Infektionskrankheiten parasitäre Krankheiten Medizin VZ AR 82 2020 0 |
| allfields_unstemmed |
10.1016/j.intimp.2020.106335 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001997.pica (DE-627)ELV05007668X (ELSEVIER)S1567-5769(19)32908-X DE-627 ger DE-627 rakwb eng 610 VZ 44.75 bkl Zhao, Jiarui verfasserin aut Osteopontin exacerbates the progression of experimental autoimmune myasthenia gravis by affecting the differentiation of T cell subsets 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Osteopontin (OPN) is an immunoregulatory factors involved in the development of autoimmune disease. • The expression of OPN is increased during the development of experiment autoimmune myasthenia gravis (EAMG). • The rats in the EAMG group were randomized to receive NaCl or different dose of OPN. • OPN could regulate the differentiation of Th cells, especially Th1 and Treg cells. Experimental autoimmune myasthenia gravis Elsevier Osteopontin Elsevier T helper cells Elsevier Autoimmune disease Elsevier B cells Elsevier Jing, Jia oth Zhao, Wei oth Li, Xinrong oth Hou, Lixuan oth Zheng, Chunfeng oth Kong, Qingfei oth Li, Wenjin oth Yao, Xiuhua oth Chang, Lulu oth Li, Hulun oth Mu, Lili oth Wang, Guangyou oth Wang, Jinghua oth Enthalten in Elsevier Science Laupland, Kevin B. ELSEVIER International immunopharmacology 2022 Amsterdam [u.a.] (DE-627)ELV00785823X volume:82 year:2020 pages:0 https://doi.org/10.1016/j.intimp.2020.106335 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.75 Infektionskrankheiten parasitäre Krankheiten Medizin VZ AR 82 2020 0 |
| allfieldsGer |
10.1016/j.intimp.2020.106335 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001997.pica (DE-627)ELV05007668X (ELSEVIER)S1567-5769(19)32908-X DE-627 ger DE-627 rakwb eng 610 VZ 44.75 bkl Zhao, Jiarui verfasserin aut Osteopontin exacerbates the progression of experimental autoimmune myasthenia gravis by affecting the differentiation of T cell subsets 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Osteopontin (OPN) is an immunoregulatory factors involved in the development of autoimmune disease. • The expression of OPN is increased during the development of experiment autoimmune myasthenia gravis (EAMG). • The rats in the EAMG group were randomized to receive NaCl or different dose of OPN. • OPN could regulate the differentiation of Th cells, especially Th1 and Treg cells. Experimental autoimmune myasthenia gravis Elsevier Osteopontin Elsevier T helper cells Elsevier Autoimmune disease Elsevier B cells Elsevier Jing, Jia oth Zhao, Wei oth Li, Xinrong oth Hou, Lixuan oth Zheng, Chunfeng oth Kong, Qingfei oth Li, Wenjin oth Yao, Xiuhua oth Chang, Lulu oth Li, Hulun oth Mu, Lili oth Wang, Guangyou oth Wang, Jinghua oth Enthalten in Elsevier Science Laupland, Kevin B. ELSEVIER International immunopharmacology 2022 Amsterdam [u.a.] (DE-627)ELV00785823X volume:82 year:2020 pages:0 https://doi.org/10.1016/j.intimp.2020.106335 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.75 Infektionskrankheiten parasitäre Krankheiten Medizin VZ AR 82 2020 0 |
| allfieldsSound |
10.1016/j.intimp.2020.106335 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001997.pica (DE-627)ELV05007668X (ELSEVIER)S1567-5769(19)32908-X DE-627 ger DE-627 rakwb eng 610 VZ 44.75 bkl Zhao, Jiarui verfasserin aut Osteopontin exacerbates the progression of experimental autoimmune myasthenia gravis by affecting the differentiation of T cell subsets 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Osteopontin (OPN) is an immunoregulatory factors involved in the development of autoimmune disease. • The expression of OPN is increased during the development of experiment autoimmune myasthenia gravis (EAMG). • The rats in the EAMG group were randomized to receive NaCl or different dose of OPN. • OPN could regulate the differentiation of Th cells, especially Th1 and Treg cells. Experimental autoimmune myasthenia gravis Elsevier Osteopontin Elsevier T helper cells Elsevier Autoimmune disease Elsevier B cells Elsevier Jing, Jia oth Zhao, Wei oth Li, Xinrong oth Hou, Lixuan oth Zheng, Chunfeng oth Kong, Qingfei oth Li, Wenjin oth Yao, Xiuhua oth Chang, Lulu oth Li, Hulun oth Mu, Lili oth Wang, Guangyou oth Wang, Jinghua oth Enthalten in Elsevier Science Laupland, Kevin B. ELSEVIER International immunopharmacology 2022 Amsterdam [u.a.] (DE-627)ELV00785823X volume:82 year:2020 pages:0 https://doi.org/10.1016/j.intimp.2020.106335 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.75 Infektionskrankheiten parasitäre Krankheiten Medizin VZ AR 82 2020 0 |
| language |
English |
| source |
Enthalten in International immunopharmacology Amsterdam [u.a.] volume:82 year:2020 pages:0 |
| sourceStr |
Enthalten in International immunopharmacology Amsterdam [u.a.] volume:82 year:2020 pages:0 |
| format_phy_str_mv |
Article |
| bklname |
Infektionskrankheiten parasitäre Krankheiten |
| institution |
findex.gbv.de |
| topic_facet |
Experimental autoimmune myasthenia gravis Osteopontin T helper cells Autoimmune disease B cells |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
International immunopharmacology |
| authorswithroles_txt_mv |
Zhao, Jiarui @@aut@@ Jing, Jia @@oth@@ Zhao, Wei @@oth@@ Li, Xinrong @@oth@@ Hou, Lixuan @@oth@@ Zheng, Chunfeng @@oth@@ Kong, Qingfei @@oth@@ Li, Wenjin @@oth@@ Yao, Xiuhua @@oth@@ Chang, Lulu @@oth@@ Li, Hulun @@oth@@ Mu, Lili @@oth@@ Wang, Guangyou @@oth@@ Wang, Jinghua @@oth@@ |
| publishDateDaySort_date |
2020-01-01T00:00:00Z |
| hierarchy_top_id |
ELV00785823X |
| dewey-sort |
3610 |
| id |
ELV05007668X |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV05007668X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624161820.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">200518s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.intimp.2020.106335</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001997.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV05007668X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1567-5769(19)32908-X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.75</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Zhao, Jiarui</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Osteopontin exacerbates the progression of experimental autoimmune myasthenia gravis by affecting the differentiation of T cell subsets</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Osteopontin (OPN) is an immunoregulatory factors involved in the development of autoimmune disease. • The expression of OPN is increased during the development of experiment autoimmune myasthenia gravis (EAMG). • The rats in the EAMG group were randomized to receive NaCl or different dose of OPN. • OPN could regulate the differentiation of Th cells, especially Th1 and Treg cells.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Experimental autoimmune myasthenia gravis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Osteopontin</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">T helper cells</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Autoimmune disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">B cells</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jing, Jia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhao, Wei</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Xinrong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hou, Lixuan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zheng, Chunfeng</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kong, Qingfei</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Wenjin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yao, Xiuhua</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chang, Lulu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Hulun</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mu, Lili</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wang, Guangyou</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wang, Jinghua</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Laupland, Kevin B. ELSEVIER</subfield><subfield code="t">International immunopharmacology</subfield><subfield code="d">2022</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00785823X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:82</subfield><subfield code="g">year:2020</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.intimp.2020.106335</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.75</subfield><subfield code="j">Infektionskrankheiten</subfield><subfield code="j">parasitäre Krankheiten</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">82</subfield><subfield code="j">2020</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| author |
Zhao, Jiarui |
| spellingShingle |
Zhao, Jiarui ddc 610 bkl 44.75 Elsevier Experimental autoimmune myasthenia gravis Elsevier Osteopontin Elsevier T helper cells Elsevier Autoimmune disease Elsevier B cells Osteopontin exacerbates the progression of experimental autoimmune myasthenia gravis by affecting the differentiation of T cell subsets |
| authorStr |
Zhao, Jiarui |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV00785823X |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 44.75 bkl Osteopontin exacerbates the progression of experimental autoimmune myasthenia gravis by affecting the differentiation of T cell subsets Experimental autoimmune myasthenia gravis Elsevier Osteopontin Elsevier T helper cells Elsevier Autoimmune disease Elsevier B cells Elsevier |
| topic |
ddc 610 bkl 44.75 Elsevier Experimental autoimmune myasthenia gravis Elsevier Osteopontin Elsevier T helper cells Elsevier Autoimmune disease Elsevier B cells |
| topic_unstemmed |
ddc 610 bkl 44.75 Elsevier Experimental autoimmune myasthenia gravis Elsevier Osteopontin Elsevier T helper cells Elsevier Autoimmune disease Elsevier B cells |
| topic_browse |
ddc 610 bkl 44.75 Elsevier Experimental autoimmune myasthenia gravis Elsevier Osteopontin Elsevier T helper cells Elsevier Autoimmune disease Elsevier B cells |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
j j jj w z wz x l xl l h lh c z cz q k qk w l wl x y xy l c lc h l hl l m lm g w gw j w jw |
| hierarchy_parent_title |
International immunopharmacology |
| hierarchy_parent_id |
ELV00785823X |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
International immunopharmacology |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV00785823X |
| title |
Osteopontin exacerbates the progression of experimental autoimmune myasthenia gravis by affecting the differentiation of T cell subsets |
| ctrlnum |
(DE-627)ELV05007668X (ELSEVIER)S1567-5769(19)32908-X |
| title_full |
Osteopontin exacerbates the progression of experimental autoimmune myasthenia gravis by affecting the differentiation of T cell subsets |
| author_sort |
Zhao, Jiarui |
| journal |
International immunopharmacology |
| journalStr |
International immunopharmacology |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2020 |
| contenttype_str_mv |
zzz |
| container_start_page |
0 |
| author_browse |
Zhao, Jiarui |
| container_volume |
82 |
| class |
610 VZ 44.75 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Zhao, Jiarui |
| doi_str_mv |
10.1016/j.intimp.2020.106335 |
| dewey-full |
610 |
| title_sort |
osteopontin exacerbates the progression of experimental autoimmune myasthenia gravis by affecting the differentiation of t cell subsets |
| title_auth |
Osteopontin exacerbates the progression of experimental autoimmune myasthenia gravis by affecting the differentiation of T cell subsets |
| abstract |
• Osteopontin (OPN) is an immunoregulatory factors involved in the development of autoimmune disease. • The expression of OPN is increased during the development of experiment autoimmune myasthenia gravis (EAMG). • The rats in the EAMG group were randomized to receive NaCl or different dose of OPN. • OPN could regulate the differentiation of Th cells, especially Th1 and Treg cells. |
| abstractGer |
• Osteopontin (OPN) is an immunoregulatory factors involved in the development of autoimmune disease. • The expression of OPN is increased during the development of experiment autoimmune myasthenia gravis (EAMG). • The rats in the EAMG group were randomized to receive NaCl or different dose of OPN. • OPN could regulate the differentiation of Th cells, especially Th1 and Treg cells. |
| abstract_unstemmed |
• Osteopontin (OPN) is an immunoregulatory factors involved in the development of autoimmune disease. • The expression of OPN is increased during the development of experiment autoimmune myasthenia gravis (EAMG). • The rats in the EAMG group were randomized to receive NaCl or different dose of OPN. • OPN could regulate the differentiation of Th cells, especially Th1 and Treg cells. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| title_short |
Osteopontin exacerbates the progression of experimental autoimmune myasthenia gravis by affecting the differentiation of T cell subsets |
| url |
https://doi.org/10.1016/j.intimp.2020.106335 |
| remote_bool |
true |
| author2 |
Jing, Jia Zhao, Wei Li, Xinrong Hou, Lixuan Zheng, Chunfeng Kong, Qingfei Li, Wenjin Yao, Xiuhua Chang, Lulu Li, Hulun Mu, Lili Wang, Guangyou Wang, Jinghua |
| author2Str |
Jing, Jia Zhao, Wei Li, Xinrong Hou, Lixuan Zheng, Chunfeng Kong, Qingfei Li, Wenjin Yao, Xiuhua Chang, Lulu Li, Hulun Mu, Lili Wang, Guangyou Wang, Jinghua |
| ppnlink |
ELV00785823X |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.intimp.2020.106335 |
| up_date |
2024-07-06T16:32:41.285Z |
| _version_ |
1803848055562174464 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV05007668X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624161820.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">200518s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.intimp.2020.106335</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001997.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV05007668X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1567-5769(19)32908-X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.75</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Zhao, Jiarui</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Osteopontin exacerbates the progression of experimental autoimmune myasthenia gravis by affecting the differentiation of T cell subsets</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Osteopontin (OPN) is an immunoregulatory factors involved in the development of autoimmune disease. • The expression of OPN is increased during the development of experiment autoimmune myasthenia gravis (EAMG). • The rats in the EAMG group were randomized to receive NaCl or different dose of OPN. • OPN could regulate the differentiation of Th cells, especially Th1 and Treg cells.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Experimental autoimmune myasthenia gravis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Osteopontin</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">T helper cells</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Autoimmune disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">B cells</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jing, Jia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhao, Wei</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Xinrong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hou, Lixuan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zheng, Chunfeng</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kong, Qingfei</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Wenjin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yao, Xiuhua</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chang, Lulu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Hulun</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mu, Lili</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wang, Guangyou</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wang, Jinghua</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Laupland, Kevin B. ELSEVIER</subfield><subfield code="t">International immunopharmacology</subfield><subfield code="d">2022</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00785823X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:82</subfield><subfield code="g">year:2020</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.intimp.2020.106335</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.75</subfield><subfield code="j">Infektionskrankheiten</subfield><subfield code="j">parasitäre Krankheiten</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">82</subfield><subfield code="j">2020</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| score |
7.400528 |